Imunon, Inc. (IMNN) has disclosed a new risk, in the Share Price & Shareholder Rights category.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Imunon, Inc. faces a significant risk from market activities such as short selling, which can lead to a decline in the market price of its Common Stock. These activities could create negative momentum, encouraging further short sales and potentially resulting in both temporary and long-term price drops. The company is unable to predict the impact of future stock issuances or sales on its market price, or how these might influence short selling activities. Consequently, large sales or the perception of potential sales could materially and adversely affect the stock’s market value.
The average IMNN stock price target is $12.00, implying 184.36% upside potential.
To learn more about Imunon, Inc.’s risk factors, click here.